In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hair Dye Literature Review Will Be Undertaken By CIR In September

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel will undertake a comprehensive literature review of hair dyes at its Sept. 8-9 meeting to evaluate the link between the use of hair dyes and incidence of cancer

You may also be interested in...



CIR Hair Dye Safety Reports, Epidemiology Statement Changes Issued

The Cosmetic Ingredient Review Expert Panel will update the discussion section of its hair dye epidemiology statement, or "boilerplate," periodically to reflect new data as it becomes available, the panel announced at a meeting in Arlington, Va., March 15-16

CIR Hair Dye Safety Reports, Epidemiology Statement Changes Issued

The Cosmetic Ingredient Review Expert Panel will update the discussion section of its hair dye epidemiology statement, or "boilerplate," periodically to reflect new data as it becomes available, the panel announced at a meeting in Arlington, Va., March 15-16

CIR Hair Dye Epidemiology Position Will Be Solidified By Early 2004

The Cosmetic Ingredient Review Expert Panel will release a hair dye epidemiology "boilerplate" stating that evidence is insufficient to prove a causal relationship exists between hair dye use and certain types by of cancer in early 2004, the panel announced

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011284

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel